[go: up one dir, main page]

ECSP099565A - Compuesto de 2-amino pirimidina - Google Patents

Compuesto de 2-amino pirimidina

Info

Publication number
ECSP099565A
ECSP099565A EC2009009565A ECSP099565A ECSP099565A EC SP099565 A ECSP099565 A EC SP099565A EC 2009009565 A EC2009009565 A EC 2009009565A EC SP099565 A ECSP099565 A EC SP099565A EC SP099565 A ECSP099565 A EC SP099565A
Authority
EC
Ecuador
Prior art keywords
pyrimidine compound
amino pyrimidine
amino
hsp
inhibitors
Prior art date
Application number
EC2009009565A
Other languages
English (en)
Inventor
Sacha Ninkovic
Michael John Bennett
Pei-Pei Kung
Jerry Jialun Meng
Buwen Huang
Luke Raymond Zhender
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP099565A publication Critical patent/ECSP099565A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente composicion se refiere a compuestos de formula (I)y sales farmaceuticamente aceptables de los mismos, a su sintesis y a su uso como inhibidores de HSP-90
EC2009009565A 2007-02-06 2009-08-06 Compuesto de 2-amino pirimidina ECSP099565A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11

Publications (1)

Publication Number Publication Date
ECSP099565A true ECSP099565A (es) 2009-09-29

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009565A ECSP099565A (es) 2007-02-06 2009-08-06 Compuesto de 2-amino pirimidina

Country Status (22)

Country Link
US (1) US20100093696A1 (es)
EP (1) EP2118111B1 (es)
JP (1) JP4523073B2 (es)
KR (1) KR20090116789A (es)
AP (1) AP2009004954A0 (es)
AT (1) ATE502944T1 (es)
AU (1) AU2008212645A1 (es)
BR (1) BRPI0807165A2 (es)
CA (1) CA2677365A1 (es)
CO (1) CO6220971A2 (es)
CR (1) CR10963A (es)
CU (1) CU20090141A7 (es)
DE (1) DE602008005715D1 (es)
DO (1) DOP2009000200A (es)
EA (1) EA200970669A1 (es)
EC (1) ECSP099565A (es)
IL (1) IL200169A0 (es)
MA (1) MA31170B1 (es)
MX (1) MX2009008386A (es)
NI (1) NI200900155A (es)
TN (1) TN2009000329A1 (es)
WO (1) WO2008096218A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2331544A1 (en) * 2008-08-13 2011-06-15 Pfizer Inc. 2-amino pyrimidine compounds as potent hsp-90 inhibitors
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
KR20130005263A (ko) 2009-12-30 2013-01-15 아르퀼 인코포레이티드 치환된 나프탈레닐-피리미딘 화합물
EP2752201A1 (en) 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. C-terminal HSP90 inhibitors to treat pituitary adenomas
CA2903431C (en) 2013-03-14 2022-12-06 Kalyra Pharmaceuticals, Inc. Bicyclopentane analgesic compounds
WO2015089170A1 (en) 2013-12-12 2015-06-18 Kalyra Pharmaceuticals, Inc. Bicyclic alkyl compounds and synthesis
CA2942144C (en) 2014-03-07 2023-08-22 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
WO2015192119A1 (en) 2014-06-13 2015-12-17 Yuma Therapeutics, Inc. Pyrimidine compounds and methods using the same
CN106999451B (zh) 2014-09-17 2021-04-02 里科瑞尔姆Ip控股有限责任公司 双环化合物
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
EP3628043A4 (en) 2017-05-15 2021-04-28 Recurium IP Holdings, LLC ANALGESIC COMPOUNDS
WO2020243457A1 (en) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Compounds and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
PE20011083A1 (es) 2000-02-15 2001-10-26 Sugen Inc 2-indolinas sustituidas con pirroles inhibidoras de proteinquinasas
US6924290B2 (en) * 2002-01-23 2005-08-02 Bayer Pharmaceuticals Corporation Rho-kinase inhibitors
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
AU2006230447A1 (en) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors

Also Published As

Publication number Publication date
JP2010518066A (ja) 2010-05-27
CO6220971A2 (es) 2010-11-19
CR10963A (es) 2009-08-27
EP2118111B1 (en) 2011-03-23
BRPI0807165A2 (pt) 2014-05-06
AP2009004954A0 (en) 2009-08-31
TN2009000329A1 (fr) 2010-12-31
CU20090141A7 (es) 2011-04-26
WO2008096218A1 (en) 2008-08-14
MA31170B1 (fr) 2010-02-01
ATE502944T1 (de) 2011-04-15
NI200900155A (es) 2010-06-30
JP4523073B2 (ja) 2010-08-11
DOP2009000200A (es) 2009-09-15
US20100093696A1 (en) 2010-04-15
DE602008005715D1 (de) 2011-05-05
AU2008212645A1 (en) 2008-08-14
MX2009008386A (es) 2009-10-16
IL200169A0 (en) 2010-04-15
EA200970669A1 (ru) 2010-02-26
KR20090116789A (ko) 2009-11-11
EP2118111A1 (en) 2009-11-18
CA2677365A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
ECSP099565A (es) Compuesto de 2-amino pirimidina
DOP2010000047A (es) Compuestos de pirazol y su uso como inhibidores de raf
CR10662A (es) Compuestos de metilpiridopirimidinona
CO6321276A2 (es) Derivados de tiazol usados como inhibidores de pi3- cinasa
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
UY31127A1 (es) Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841
UY33226A (es) Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
CR11826A (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotrópicos de glutamato
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
ECSP099571A (es) Derivados pirazólicos como inhibidores de la 11-beta-hsd1
UY32296A (es) Nuevos compuestos
CU20090072A7 (es) Ácido l-glutámico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación
ECSP099442A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
SV2009003389A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
UY32954A (es) PIRIMIDINAS SUSTITUIDAS CON ADAMANTILIMINOCARBONILO COMO INHIBIDORES DE 11-ß-HSD1 826?.
DOP2010000155A (es) Derivados de pirazol como inhibidores de 5-lo
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
ECSP11011053A (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
UY31161A1 (es) Usos de derivados de cinolina en el tratamiento de la esquizofrenia
ECSP10010412A (es) Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-diamina y su uso como antipsicótico
CU20100127A7 (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
CU20100018A7 (es) Compuestos de pirazol